Web site is worth a read
https://neuroscientific.com/our-science/
Biopharmaceutical innovation and world class R&DNSB (ASX:NSB) is a drug development company focused on developing peptide-based pharmaceutical drugs for the treatment of neurodegenerative conditions with high unmet medical need.The NSB product portfolio includes several therapeutic peptides that are modeled on the domains of a naturally occurring protein called Metallothionein-II (MT-II).EmtinB is the lead candidate that has shown to closely mimic the neuroprotective and neuroregenerative ability of MT-II.
EmtinB is currently being developed as a treatment for neurodegenerative dementia and Alzheimer’s disease, and degenerative conditions of the optic nerve.
Web site is worth a...
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.652M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.5¢ | $1.564K | 34.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2221 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 8000 | 1 |
View Market Depth
| Last trade - 14.18pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.5¢ |
Change
0.000 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 4.5¢ | 4.5¢ | 4.5¢ | 37221 | ||
| Last updated 14.18pm 10/05/2024 ? | |||||
| NSB (ASX) Chart |